CEO and Co-Founder

Nader Alaghband

Education

AB, Cornell University; EMBA, University of Chicago.

Training

Certifications

BIO

Nader has 30 years direct and indirect experience of chronic inflammatory disease. Over the last 15 years he has worked at the intersection of social impact and emerging technologies, helping health systems, patient groups and pharmaceutical companies identify and capitalise on opportunities to deploy high impact, population  scale platforms in the UK, Europe and Asia. Before starting his career in tech, Nader worked in foreign policy, civil society and international development at think tanks and research organisations in London and New York.

PROFESSIONAL ACCOMPLISHMENTS

AFFILIATIONS

Various advisory boards and mentoring programmes.

RECENT PUBLICATIONS

Ampersand Health Selected for PharmStars Accelerator Programme

06 Dec 2023

Ampersand Health, alongside 10 other leading health tech innovations, has successfully graduated from PharmStars.

US Researchers from University of Michigan & University of Minnesota Evaluate Behaviour Change Techniques in IBD Management Apps

05 Dec 2023

Researchers from The University of Michigan and University of Minnesota Medical School conducted a study titled "Use of Behavior Change Techniques and Quality...

Researchers from Mount Sinai Conduct Study Including My IBD Care

20 Sep 2023

Researchers from Mount Sinai, one of the largest teaching hospitals in the US, conducted a study on digital support tools for people with IBD, including My IBD...

Ampersand Health Featured in BMJ

22 Jun 2023

Our work on patient initiated follow-up using our My IBD Care app, along with self-monitoring of calprotectin through our CalproSmart™ ™ integration,...

Hull University Teaching Hospitals Study on My IBD Care & Calprotectin Testing

20 Jun 2023

Hull University Teaching Hospitals conducted a study on incorporating Ampersand’s patient-facing app and home calprotectin based PIFU and monitoring in IBD...

My IBD Care

My Arthritis